$12.96
-0.540 (-4.00%)
At Close: Jul 11, 2025
Catalyst Biosciences Earnings Calls
Mar 31, 2025
Release date | May 14, 2025 |
EPS estimate | - |
EPS actual | -$0.0400 |
Revenue estimate | - |
Revenue actual | 22.058M |
Sep 30, 2023
-$0.0400 (20.00%)
Release date | Oct 26, 2023 |
EPS estimate | -$0.0500 |
EPS actual | -$0.0400 |
EPS Surprise | 20.00% |
Revenue estimate | - |
Revenue actual | - |
Jun 30, 2023
Release date | Aug 14, 2023 |
EPS estimate | -$0.0700 |
EPS actual | -$0.0700 |
Revenue estimate | - |
Revenue actual | - |
Mar 31, 2023
-$0.110 (-57.14%)
Release date | May 15, 2023 |
EPS estimate | -$0.0700 |
EPS actual | -$0.110 |
EPS Surprise | -57.14% |
Revenue estimate | - |
Revenue actual | - |
Last 4 Quarters for Catalyst Biosciences
Below you can see how CBIO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Mar 31, 2023
Missed
Release date | May 15, 2023 |
Price on release | $0.220 |
EPS estimate | -$0.0700 |
EPS actual | -$0.110 |
EPS surprise | -57.14% |
Date | Price |
---|---|
May 09, 2023 | $0.211 |
May 10, 2023 | $0.220 |
May 11, 2023 | $0.226 |
May 12, 2023 | $0.221 |
May 15, 2023 | $0.220 |
May 16, 2023 | $0.230 |
May 17, 2023 | $0.230 |
May 18, 2023 | $0.227 |
May 19, 2023 | $0.232 |
4 days before | 4.22% |
4 days after | 5.45% |
On release day | 4.55% |
Change in period | 9.90% |
Jun 30, 2023
Release date | Aug 14, 2023 |
Price on release | $0.349 |
EPS estimate | -$0.0700 |
EPS actual | -$0.0700 |
Date | Price |
---|---|
Aug 08, 2023 | $0.340 |
Aug 09, 2023 | $0.342 |
Aug 10, 2023 | $0.340 |
Aug 11, 2023 | $0.336 |
Aug 14, 2023 | $0.349 |
Aug 15, 2023 | $0.370 |
Aug 16, 2023 | $0.439 |
Aug 17, 2023 | $0.480 |
Aug 18, 2023 | $0.542 |
4 days before | 2.68% |
4 days after | 55.31% |
On release day | 5.99% |
Change in period | 59.47% |
Sep 30, 2023
Beat
Release date | Oct 26, 2023 |
Price on release | $0.539 |
EPS estimate | -$0.0500 |
EPS actual | -$0.0400 |
EPS surprise | 20.00% |
Date | Price |
---|---|
Oct 20, 2023 | $0.500 |
Oct 23, 2023 | $0.466 |
Oct 24, 2023 | $0.431 |
Oct 25, 2023 | $0.530 |
Oct 26, 2023 | $0.539 |
Oct 27, 2023 | $0.525 |
Oct 30, 2023 | $0.511 |
Oct 31, 2023 | $0.511 |
Nov 01, 2023 | $0.511 |
4 days before | 7.80% |
4 days after | -5.14% |
On release day | -2.56% |
Change in period | 2.26% |
Mar 31, 2025
Release date | May 14, 2025 |
Price on release | $0.511 |
EPS estimate | - |
EPS actual | -$0.0400 |
Date | Price |
---|---|
Dec 08, 2023 | $0.511 |
Dec 11, 2023 | $0.511 |
Dec 12, 2023 | $0.511 |
Dec 13, 2023 | $0.511 |
Dec 14, 2023 | $0.511 |
Jun 17, 2025 | $13.27 |
Jun 18, 2025 | $14.62 |
Jun 20, 2025 | $15.00 |
Jun 23, 2025 | $15.30 |
4 days before | 0% |
4 days after | 2,892.37% |
On release day | 2,495.35% |
Change in period | 2,892.37% |
Catalyst Biosciences Earnings History
Earnings Calendar
FAQ
What is the CBIO price-to-earnings (P/E) ratio?
CBIO P/E ratio as of Jul 11, 2025 (TTM) is 48.32.
What are Catalyst Biosciences's retained earnings?
On its balance sheet, Catalyst Biosciences reported retained earnings of $22.06 million for the latest quarter ending Mar 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.